Finance

Beta
Ask
Lists
OGEN:NYSEAMERICAN
Oragenics Inc
$0.55
-9.95%
(-0.061) 1D
$0.57
+4.20% (+0.023)
After hours
Closed: Jun 18, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OGEN...
Open
$0.62
High
$0.62
Low
$0.55
Mkt. cap
2.48M
Avg. vol.
53.77K
Volume
94.05K
52-wk high
$4.19
52-wk low
$0.50
EPS
-$6.12
Beta
1.27
Shares outstanding
4.51M
No. of employees
3
Open
$0.62
High
$0.62
Low
$0.55
Mkt. cap
2.48M
Avg. vol.
53.77K
Volume
94.05K
52-wk high
$4.19
52-wk low
$0.50
EPS
-$6.12
Beta
1.27
Shares outstanding
4.51M
No. of employees
3
News stories
From sources across the web
About Oragenics Inc
CEO-
Employees3
Founded1996
HeadquartersLakewood Ranch, Florida, United States
SectorBiotechnology
Websiteoragenics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
449.68K
930.89K
670.54K
645.47K
Cost of revenue
449.68K
930.89K
670.54K
645.47K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.26M
2.19M
1.83M
1.61M
Operating expense
1.26M
2.19M
1.83M
1.61M
Total operating expenses
1.71M
3.12M
2.50M
2.26M
Operating income
-1.71M
-3.12M
-2.50M
-2.26M
Other non operating income
-
-
-
-
EBT including unusual items
-2.27M
-3.07M
-2.42M
-2.22M
EBT excluding unusual items
-2.27M
-3.07M
-2.42M
-2.22M
Income tax expense
-
-
-136.91K
-22.62K
Effective tax rate
-
-
5.65%
1.02%
Other operating expenses
-
-
-
-
Net income
-2.27M
-3.07M
-2.29M
-2.20M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
16.79K
68.14K
87.09K
40.88K
Interest expense
-572.31K
-7.04K
-7.45K
-3.73K
Net interest expenses
-555.52K
61.10K
79.64K
37.15K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer